Kaplan–Meier statistics confirmed a significant lower overall survival (OS) in higher tumor stage (pT2 and above) (p = 0.0096) and in nodal positive cases (p = 0.0028) especially within the first 120 months after diagnosis, also after adjusting for HER2‐status. The gene discussed is ERBB2; the disease is neoplasm.